Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Astellas Pharma Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its strategic focuses and progress in delivering long-term impact for patients, partners, and shareholders [1][2] Company Strategy and Leadership - President and CEO Naoki Okamura will discuss Astellas' key growth drivers and commitment to disciplined execution, while Chief Research & Development Officer Tadaaki Taniguchi will emphasize advancements in transformative scientific breakthroughs for diseases with high unmet medical needs [2][3] - The company aims to turn innovative science into meaningful value for patients and drive sustainable growth, using the conference as a platform to engage with the global investment and healthcare community [3] Event Details - The presentation will take place on January 12, 2026, at 3:00 p.m. PT at the Westin St. Francis, San Francisco, with materials and a live webcast available on Astellas' Investor Relations page [8] Industry Engagement - Astellas is also a distinguished sponsor of the Biotech Showcase, further enhancing its visibility in the global life sciences community, with Chief Strategy Officer Adam Pearson participating in discussions on partnering trends that advance emerging technologies and drug development innovation [4]